Stride Inc (LRN)
Return on equity (ROE)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 204,183 | 184,773 | 170,548 | 154,417 | 126,867 | 111,585 | 99,042 | 90,341 | 107,130 | 89,535 | 70,405 | 52,902 | 71,451 | 65,844 | 50,809 | 46,902 | 24,506 | 22,935 | 32,643 | 35,761 |
Total stockholders’ equity | US$ in thousands | 1,176,020 | 1,103,210 | 1,032,680 | 958,493 | 947,296 | 899,361 | 841,899 | 786,823 | 812,581 | 780,570 | 734,233 | 719,906 | 804,648 | 786,779 | 752,429 | 719,021 | 675,329 | 664,628 | 651,096 | 624,712 |
ROE | 17.36% | 16.75% | 16.52% | 16.11% | 13.39% | 12.41% | 11.76% | 11.48% | 13.18% | 11.47% | 9.59% | 7.35% | 8.88% | 8.37% | 6.75% | 6.52% | 3.63% | 3.45% | 5.01% | 5.72% |
June 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $204,183K ÷ $1,176,020K
= 17.36%
The return on equity (ROE) for Stride Inc has shown a generally positive trend over the past several quarters, indicating an improvement in the company's ability to generate profits from its shareholder's equity.
Starting from a ROE of 5.72% in the fourth quarter of 2019, there has been a consistent upward trajectory in ROE, with occasional fluctuations. The most recent ROE as of June 30, 2024, stands at 17.36%, reflecting a significant increase compared to previous periods.
The ROE figures suggest that Stride Inc has been effectively utilizing its equity to generate earnings for its shareholders, which is a positive sign of financial performance and efficiency. Overall, the trend indicates that the company's profitability and efficiency have been on an upward trend, showcasing improved performance and potential for sustained growth.
Peer comparison
Jun 30, 2024